This funding will boost the US’s antibiotic manufacturing capacity, while helping to curb the threat of antimicrobial ...
The U.S. government awarded Shionogi Inc. a contract worth up to $482 million to expand domestic manufacturing of Fetroja ...
Program Includes Establishing Pharmaceutical Manufacturing in the U.S., Procurement and Development of Treatment for Infections Caused by Biothreat Pathogens OSAKA, Japan--(BUSINESS WIRE)--April 08, ...